HIV – Global Health Press

Latest Science

New vaccine platform could ease development, delivery of virus-fighters

To many, EV stands for “electric vehicle.” To researchers at Harvard University and the University of Nebraska–Lincoln, it’s shorthand for another vehicle — this one nanoscopic — that might help streamline the...

28 January, 2023

4 min read

Latest Science

Early action needed to prevent treatment failure, Nigerian research on detectable virus levels shows

National HIV treatment programmes should not wait until people with HIV have viral loads above 1000 copies/ml to provide enhanced adherence counselling, Nigerian researchers report in the journal Lancet Global Health...

16 January, 2023

6 min read

Latest Science

First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells...

4 October, 2022

6 min read

Latest Science

New study identifies African “hotspot” for highly infectious diseases

A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response. The new research, published in BMJ Global...

2 March, 2022

2 min read

Latest Science

Trials start of mRNA vaccine for HIV

First steps towards protection from the many and variable viral strains Volunteers in the US recently received the first experimental doses of a new type of HIV vaccine. Using Moderna’s mRNA platform, the vaccine has...

11 February, 2022

6 min read

Latest Science

HIV vaccine candidate’s mechanism revealed 20 years later

About two decades after first devising a new kind of vaccine, Oregon Health & Science University (OHSU) researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half...

26 April, 2021

3 min read

Latest Science

HIV vaccine that generates broadly neutralizing antibodies passes first safety and proof-of-concept study in humans

Scientists are engineering vaccines that turn cells into antibody factories The Conference on Retroviruses and Opportunistic Infections (CROI 2020) heard this week how scientists had, for the first time, devised a...

16 March, 2020

10 min read

Latest Science

Experimental HIV vaccine successfully elicits broadly neutralizing antibodies to the virus

An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety...

21 November, 2019

6 min read

Latest Science

Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests

A new approach that targets young immune cells may also work for creating vaccines against the flu, dengue, malaria and hepatitis C. A collaborative team of scientists has made a successful proof-of-principle...

13 November, 2019

6 min read

Latest Science

New HIV vaccine promises to protect people against toughest strains

The federal government estimates that there are more than one million people living with HIV to date in the U.S. Among these people, one in every seven may not know that they are infected. Researchers from Scripps...

26 July, 2019

2 min read

Tag - HIV